← Back to headlines

Novo Nordisk Boosts Forecast on Soaring GLP-1 Sales
Novo Nordisk A/S raised its forecast for the second time this year, citing higher expectations for its obesity and diabetes drug sales.
4 Aug, 16:48 — 4 Aug, 16:48
Sources
Showing 1 of 3 sources
Coverage Timeline
First report: bloomberg · 4 Aug, 16:48|Full coverage: 3 · 7m|Window: 7m
Left-leaningCenterRight-leaning

